Literature DB >> 27054651

Multiple Overimputation to Address Missing Data and Measurement Error: Application to HIV Treatment During Pregnancy and Pregnancy Outcomes.

Angela M Bengtson1, Daniel Westreich, Patrick Musonda, Audrey Pettifor, Carla Chibwesha, Benjamin H Chi, Bellington Vwalika, Brian W Pence, Jeffrey S A Stringer, William C Miller.   

Abstract

BACKGROUND: Investigations of the association of combination antiretroviral therapy (ART) with pregnancy outcomes often rely on routinely collected clinical data, which are prone to missing data and measurement error. Measurement error in gestational age may bias the relation between combination ART and gestational age-based outcomes.
METHODS: We demonstrate the use of multiple overimputation to address missing data and measurement error in gestational age. Using routinely collected clinical data from public health facilities in Lusaka, Zambia, we multiply imputed missing data and multiply overimputed observed values of gestational age. Poisson models with robust variance estimators were used to estimate risk ratios (RRs) for the associations of duration of combination ART with small for gestational age (SGA) and preterm birth. We compared results from a complete-case analysis, using multiple imputation to address missing data only and using multiple overimputation to address missing data and measurement error.
RESULTS: In the complete-case analysis, there was no evidence of an association between duration of combination ART and SGA or preterm birth. When we performed multiple overimputation, RRs for SGA moved past the null, but remained imprecise. For preterm birth, RRs for 9-32 weeks of combination ART moved away from the null as the variance due to measurement error increased.
CONCLUSION: When we used multiple overimputation to account for measurement error and missing data, we observed an increased risk of preterm birth with longer duration of combination ART. Future analyses examining associations between combination ART and pregnancy outcomes should consider using multiple overimputation to address measurement error in gestational age.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27054651      PMCID: PMC5019179          DOI: 10.1097/EDE.0000000000000494

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  32 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Splines for trend analysis and continuous confounder control.

Authors:  Chanelle J Howe; Stephen R Cole; Daniel J Westreich; Sander Greenland; Sonia Napravnik; Joseph J Eron
Journal:  Epidemiology       Date:  2011-11       Impact factor: 4.822

3.  Misclassification of gestational age in the study of spontaneous abortion.

Authors:  Penelope P Howards; Irva Hertz-Picciotto; Clarice R Weinberg; Charles Poole
Journal:  Am J Epidemiol       Date:  2006-09-19       Impact factor: 4.897

4.  Combination antiretroviral therapy and duration of pregnancy.

Authors: 
Journal:  AIDS       Date:  2000-12-22       Impact factor: 4.177

5.  Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.

Authors:  Kathleen M Powis; Douglas Kitch; Anthony Ogwu; Michael D Hughes; Shahin Lockman; Jean Leidner; Erik van Widenfelt; Claire Moffat; Sikhulile Moyo; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

6.  Perinatal complications in women with gestational diabetes mellitus.

Authors:  J A Svare; B B Hansen; L Mølsted-Pedersen
Journal:  Acta Obstet Gynecol Scand       Date:  2001-10       Impact factor: 3.636

7.  Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Authors:  Jennifer Y Chen; Heather J Ribaudo; Sajini Souda; Natasha Parekh; Anthony Ogwu; Shahin Lockman; Kathleen Powis; Scott Dryden-Peterson; Tracy Creek; William Jimbo; Tebogo Madidimalo; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

8.  Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Authors:  Didier K Ekouevi; Patrick A Coffie; Renaud Becquet; Besigin Tonwe-Gold; Appolinaire Horo; Rodolphe Thiebaut; Valériane Leroy; Stéphane Blanche; François Dabis; Elaine J Abrams
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

9.  Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.

Authors:  Karin van der Merwe; Risa Hoffman; Vivian Black; Matthew Chersich; Ashraf Coovadia; Helen Rees
Journal:  J Int AIDS Soc       Date:  2011-08-15       Impact factor: 5.396

10.  HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction.

Authors:  Eszter Papp; Hakimeh Mohammadi; Mona R Loutfy; Mark H Yudin; Kellie E Murphy; Sharon L Walmsley; Rajiv Shah; Jay MacGillivray; Michael Silverman; Lena Serghides
Journal:  J Infect Dis       Date:  2014-07-16       Impact factor: 5.226

View more
  1 in total

1.  Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region.

Authors:  Marie C D Stoner; Bellington Vwalika; Marcela Smid; Andrew Kumwenda; Elizabeth Stringer; Benjamin H Chi; Jeff S A Stringer
Journal:  Am J Trop Med Hyg       Date:  2016-10-31       Impact factor: 2.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.